Palo Alto, CA, United States of America

Peter I Adriaenssens


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter I Adriaenssens

Introduction

Peter I Adriaenssens is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of appetite suppression through his innovative methods and compounds. With a total of two patents to his name, Adriaenssens has focused on developing solutions that address both appetite control and related behavioral issues.

Latest Patents

Adriaenssens' latest patents include a method for suppressing appetite by the administration of specific compounds. These compounds are designed to alter macronutrient preferences and are characterized by a defined quantitative structure-activity relationship (QSAR). The first patent details compounds of formula I that are useful for suppressing appetite, where the substituents are selected to meet specific QSAR criteria. The second patent expands on this concept, indicating that these compounds can also suppress obsessive-compulsive behavior and inhibit cravings and substance abuse.

Career Highlights

Peter I Adriaenssens is associated with Neurex Corporation, where he continues to work on innovative solutions in the field of appetite suppression. His research has the potential to impact various aspects of health and wellness, particularly in managing eating behaviors and related disorders.

Collaborations

Adriaenssens has collaborated with notable colleagues, including Jack D Barchas and Glen R Elliott. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Peter I Adriaenssens stands out as an influential inventor in the realm of appetite suppression. His innovative patents and collaborations reflect his commitment to addressing important health issues through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…